Question

while expected return is 6.5, and assuming that the expected return on Royalty Pharma's debt is...

while expected return is 6.5, and assuming that the expected return on Royalty Pharma's debt is 3% per year, calculate the expected return on Royalty Pharma's equity? Recall that Royalty Pharma finances its acquisitions by an approximatley even mixture of debt and equity: $4.2 billion and $4.0 billion, respectively. (Note: Your answer should be a number in percentage form. not entering '%'.

Homework Answers

Answer #1
Weighted average cost of capital (WACC) = [(S/S+B)*Rs + (B/S+B)*Rb(1-tc)]
S = equity, B = debt, Rs = Cost of equity, Rb = cost of debt,
tc = corporations tax rate
Expected return/WACC 6.50%
Expected return on debt/cost of debt 3%.
S (total equity) 4 billion
B (total debt) 4.2 billion
S/(S+B) 4/(4+4.2)
S/(S+B) 0.4878
B/(S+B) 4.2/(4+4.2)
B/(S+B) 0.5122
.065 = .4878*Rs + .5122*(.03)
.065 = .4878*Rs + .015366
.4878*Rs = .049634
Rs = .049634/.4878
Rs = .101751
Expected return on equity/cost of equity 10.18%
The expected return on Royalty Pharma's equity is 10.18
Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Suppose the portfolio of a large institutional investor “Parthenon” has an expected return of 13 percent...
Suppose the portfolio of a large institutional investor “Parthenon” has an expected return of 13 percent and its beta relative to the market portfolio is 2, while its return’s standard deviation is 8 percent. Suppose there is a firm called “Atlantis”, whose equity beta is 2. The equity value of “Atlantis” is £1 million and its debt is worth £1.5 million. Its debt is a consol bond (i.e. perpetual bond) with an annual coupon of £45,000. The present value of...
A bio-technology company is looking to invest $25 billion in new technology that is expected to...
A bio-technology company is looking to invest $25 billion in new technology that is expected to produce incremental cash flows of $7 billion, $10 billion, and $12 billion in each of the next three years, respectively. The CFO has asked that you and your team determine whether or not the company should invest in the new technology. In order to finance the project, the company will issue new bonds and new equity. Of the $25 billion in costs, $16 billion...
Kaelea, Inc., has no debt outstanding and a total market value of $63,000. Earnings before interest...
Kaelea, Inc., has no debt outstanding and a total market value of $63,000. Earnings before interest and taxes, EBIT, are projected to be $8,600 if economic conditions are normal. If there is strong expansion in the economy, then EBIT will be 21 percent higher. If there is a recession, then EBIT will be 34 percent lower. The company is considering a $21,300 debt issue with an interest rate of 8 percent. The proceeds will be used to repurchase shares of...
Kaelea, Inc., has no debt outstanding and a total market value of $100,000. Earnings before interest...
Kaelea, Inc., has no debt outstanding and a total market value of $100,000. Earnings before interest and taxes, EBIT, are projected to be $8,400 if economic conditions are normal. If there is strong expansion in the economy, then EBIT will be 24 percent higher. If there is a recession, then EBIT will be 31 percent lower. The company is considering a $35,000 debt issue with an interest rate of 6 percent. The proceeds will be used to repurchase shares of...
A bio-technology company is looking to invest $25 billion in new technology that is expected to...
A bio-technology company is looking to invest $25 billion in new technology that is expected to produce incremental cash flows of $7 billion, $10 billion, and $12 billion in each of the next three years, respectively. The CFO has asked that you and your team determine whether or not the company should invest in the new technology. In order to finance the project, the company will issue new bonds and new equity. Of the $25 billion in costs, $16 billion...
‏__ 39. Suppose the U.S. Treasury announces plans to issue $50 billion of new bonds. Assuming...
‏__ 39. Suppose the U.S. Treasury announces plans to issue $50 billion of new bonds. Assuming the announcement was not expected, what effect, other things held constant, would that have on bond prices and interest rates? a. Prices and interest rates would both rise. b. Prices would rise and interest rates would decline. c. Prices and interest rates would both decline. d. There would be no changes in either prices or interest rates. e. Prices would decline and interest rates...
Chapter 6 13. Consider the following bonds: Bond Coupon Rate (annual payments) Maturity (years) A 0%...
Chapter 6 13. Consider the following bonds: Bond Coupon Rate (annual payments) Maturity (years) A 0% 15 B 0% 10 C 4% 15 D 8% 10 What is the percentage change in the price of each bond if its yield to maturity falls from 6% to 5%? Which of the bonds A–D is most sensitive to a 1% drop in interest rates from 6% to 5% and why? Which bond is least sensitive? Provide an intuitive explanation for your answer....
Homeplate Lexi Taylor looked out the window of her Rexburg apartment and marveled at how her...
Homeplate Lexi Taylor looked out the window of her Rexburg apartment and marveled at how her life had changed in the past few months. Since launching Homeplate a little over a year ago, she had grown from a one-person operation preparing meals in the local YMCA kitchen to a fast growing meal preparation and delivery service, with nearly 3,000 regular customers and strong growth and profit potential. Lexi had gone through raising a seed round of capital and was now...
Question: Assuming that a vaccine is discovered in say 18 months, discuss what might have happened...
Question: Assuming that a vaccine is discovered in say 18 months, discuss what might have happened to the LRAS curve over the period of the COVID crisis. Although the virus has delayed the budget until October …. last week the secretary to the Treasury dropped some big hints on what to expect. In evidence to the Senate committee inquiring into the response to the virus, Dr Steven Kennedy started with the outlook for the labour market. The latest figures from...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly O'Brien, David Roberts, and Barbara Smalley. O'Brien and Roberts, both MDs, were on the research faculty at the Chicago Medical School at the time; O'Brien specialized in biochemistry and molecular biology, and Roberts specialized in immunology and medical microbiology. Smalley, who has a PhD, served a department chair of the Microbiology Department at the same school. The company started as a research and development...